Literature DB >> 12955615

Fifty years' experience of reduced-tar cigarettes: what do we know about their health effects?

Geoffrey C Kabat1.   

Abstract

Since the 1950s, cigarettes sold in the United States have undergone a progressive modification, including the addition of filters and a reduction in the average machine-measured tar and nicotine yield per cigarette by over 60%. These, and other, temporal changes in manufactured cigarettes, coupled with the complexity of smoking behavior, make it difficult to assess the impact of the newer cigarettes on health. Recently, some researchers have suggested that the newer products, marketed as being less harmful, may in fact provide no benefit compared to the older, higher tar cigarettes. The primary purpose of this review is to critically evaluate the available epidemiologic evidence on the health effects of low-tar cigarettes. This body of data provides the only means of assessing the effects of long-term exposure to these products, as they are actually used. After identifying important methodological problems confronting research in this area, studies of lung cancer, coronary heart disease, chronic obstructive pulmonary disease, and total mortality are examined in terms of their strengths and weaknesses and their results. Thirty-five studies of lung cancer are suggestive that smokers of low tar cigarettes have a lower risk (by 20-30%) compared to smokers of higher tar cigarettes. Only a minority of studies of heart disease provide evidence of a reduction in risk, on the order of 10%. Studies concerning chronic obstructive pulmonary disease (COPD) are inconsistent, but the majority suggest decreased risk in smokers of lower tar cigarettes. Finally, studies that included total mortality indicate with a high degree of consistency that the total death rate is reduced in smokers of lower tar cigarettes, on the order of 10-20%. Because of the multiplicity of factors involved in smoking behavior, including compensation for reduced nicotine, and the modest magnitude of the apparent reduction in risk, the relative benefits of low tar cigarettes remain uncertain. Additional analyses of existing data sets could further clarify the impact of low-tar cigarettes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955615     DOI: 10.1080/08958370390228547

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  8 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

2.  Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung.

Authors:  Samuel Santos Valenca; Paulo Castro; Wagner Alves Pimenta; Manuella Lanzetti; Simone Vargas Silva; Cristina Barja-Fidalgo; Vera Lúcia Gonçalves Koatz; Luís Cristóvão Porto
Journal:  Int J Exp Pathol       Date:  2006-10       Impact factor: 1.925

3.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

4.  Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies.

Authors:  Gavin Pickett; Jeanclare Seagrave; Susan Boggs; Gregory Polzin; Patricia Richter; Yohannes Tesfaigzi
Journal:  Toxicol Sci       Date:  2009-12-15       Impact factor: 4.849

5.  Smoking cessation intervention for female prisoners: addressing an urgent public health need.

Authors:  Karen Cropsey; Gloria Eldridge; Michael Weaver; Gabriela Villalobos; Maxine Stitzer; Al Best
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

6.  Invasion-inhibiting Effects of Gaseous Components in Cigarette Smoke on Mouse Rectal Carcinoma Colon-26 Cells.

Authors:  Mayuko Hatai; Noriko Yoshikawa; Eriko Kinoshita; Shizuyo Horiyama; Satomi Kagota; Kazumasa Shinozuka; Kazuki Nakamura
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

7.  Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products.

Authors:  Carole L Yauk; Andrew Williams; Julie K Buick; Guosheng Chen; Rebecca M Maertens; Sabina Halappanavar; Paul A White
Journal:  Environ Mol Mutagen       Date:  2012-03-19       Impact factor: 3.216

8.  A randomized controlled trial of a smoking cessation intervention conducted among prisoners.

Authors:  Robyn Richmond; Devon Indig; Tony Butler; Kay Wilhelm; Vicki Archer; Alex Wodak
Journal:  Addiction       Date:  2013-03-11       Impact factor: 6.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.